Typhoid Vaccine
- TRADE NAMES: Typherix (GSK); Typhim Vi (Sanofi Pasteur); Vivotif (Berna Biotech)
- INDICATIONS: Immunization against typhoid fever
- CLASS: Vaccine
- HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Antibiotics, Antimalarials, Atovaquone/Proguanil, Azathioprine, Belimumab, Cefixime, Ceftaroline Fosamil, Ceftobiprole, Chloroquine, Ciprofloxacin, Corticosteroids, Daptomycin, Fingolimod, Gemifloxacin, Hydroxychloroquine, Immunosuppressants, Interferon Gamma, Leflunomide, Mefloquine, Mercaptopurine, Sulfonamides, Telavancin, Tigecycline, Tinidazole, Tocilizumab, Ustekinumab
PREGNANCY CATEGORY: C
Vivotif is a live oral vaccine.
Please login to see the rest of this drug profile
SKIN.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric